CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Cash flows from operating activities:
Net loss	$ (2,293,128)	$ (9,020,247)
Net cash used in operating activities:
Stock-based compensation	1,949,395	8,066,986
Waiver of common stock issuable	(1,542,000)
Changes in operating assets and liabilities:
Research and development tax credit receivable	(251,472)	(155,816)
Other tax receivable	(67,315)	63,774
Joint development cost receivable	(31,340)	109,124
Prepaid expenses	(184,472)	(208,344)
Prepaid expenses - related party	(244,882)	112,218
Accounts payable and accrued liabilities	(376,529)	22,534
Accounts payable and accrued liabilities - related parties	60,871	(136,917)
Operating lease liability - related party	(24,653)
Net cash used in operating activities	(3,005,525)	(1,146,688)
Cash flows from financing activities:
Net proceeds from sale of common stock	12,209,021	900,000
Net cash provided by financing activities	12,209,021	900,000
Impact on cash from foreign currency translation	(25,736)	(15,610)
Net increase in cash and cash equivalents	9,177,760	(262,298)
Cash and cash equivalents - beginning	186,204	1,370,711
Cash and cash equivalents - ending	9,363,964	1,108,413
Cash paid during the period for:
Income Taxes	0	0
Interest	0	$ 0
Noncash investing and financing activity:
Issuance of warrants to placement agents	247,452
Issuance of common stock issuable	$ 3,084,000